Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

Name: Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced malignant solid neoplasm, metastatic malignant solid neoplasm, unresectable malignant solid neoplasm

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 125822
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.